Literature DB >> 18466395

Helicobacter pylori-pulsed dendritic cells induce H. pylori-specific immunity in mice.

Min Zhang1, Bradford E Berndt, Kathryn A Eaton, Sivaprakash Rathinavelu, Anna Pierzchala, John Y Kao.   

Abstract

BACKGROUND: The growing concern over the emergence of antibiotic-resistant Helicobacter pylori infection is propelling the development of an efficacious vaccine to control this highly adaptive organism. AIM: We studied the use of a dendritic cell (DC)-based vaccine against H. pylori infection in mice.
METHODS: The cellular immune responses to murine bone marrow-derived DCs pulsed with phosphate-buffered saline (PBS-DC) or live H. pylori SS1 (HP-DC) were assessed in vitro and in vivo. The protective immunity against H. pylori SS1 oral challenge was compared between HP-DC or PBS-DC immunized mice. The effect of regulatory T-cell (Treg) depletion by anti-CD25 antibody on HP-DC vaccine efficacy was also evaluated.
RESULTS: HP-DC induced a Th1-dominant response in vitro. In vivo, HP-DC immunized mice were characterized by a mixed Th1/Th2 peripheral immune response. However, in the stomach, HP-DC immunized mice expressed a higher level of IFN-gamma compared to PBS-DC immunized mice; no difference was found for interleukin-5 expressions in the stomach. A lower bacterial colonization post-H. pylori challenge was observed in HP-DC immunized mice compared to PBS-DC immunized mice with no significant difference in gastritis severity. H. pylori-specific Th1 response and protective immunity were further enhanced in vivo by depletion of Treg with anti-CD25 antibody.
CONCLUSION: DC-based anti-H. pylori vaccine induced H. pylori-specific helper T-cell responses capable of limiting bacterial colonization. Our data support the critical role of effector cellular immune response in the development of H. pylori vaccine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466395      PMCID: PMC2871674          DOI: 10.1111/j.1523-5378.2008.00606.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  23 in total

1.  Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies.

Authors:  P Sutton; J Wilson; T Kosaka; I Wolowczuk; A Lee
Journal:  Immunol Cell Biol       Date:  2000-02       Impact factor: 5.126

Review 2.  Dendritic cell-based vaccination against cancer.

Authors:  Hiroaki Saito; Davor Frleta; Peter Dubsky; A Karolina Palucka
Journal:  Hematol Oncol Clin North Am       Date:  2006-06       Impact factor: 3.722

3.  Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.

Authors:  Ali A Akhiani; Jacques Pappo; Zita Kabok; Karin Schön; Wei Gao; Lennart E Franzén; Nils Lycke
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

4.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.

Authors:  J G Fox; P Beck; C A Dangler; M T Whary; T C Wang; H N Shi; C Nagler-Anderson
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice.

Authors:  K A Eaton; M Mefford; T Thevenot
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

6.  Transfer of antigen-pulsed dendritic cells induces specific T-Cell proliferation and a therapeutic effect against long-term Helicobacter pylori infection in mice.

Authors:  Satoshi Otsu; Kazuyo Gotoh; Tetsu Yamashiro; Junpei Yamagata; Kouichirou Shin; Toshio Fujioka; Akira Nishizono
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.

Authors:  John Y Kao; Min Zhang; Chuan-Min Chen; Anna Pierzchala; Jian-Jun Chen
Journal:  Immunol Lett       Date:  2005-12-19       Impact factor: 3.685

Review 8.  Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.

Authors:  Herbert Hoffelner; Gabriele Rieder; Rainer Haas
Journal:  Int J Med Microbiol       Date:  2007-08-21       Impact factor: 3.473

9.  Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent.

Authors:  Christine A Garhart; Frederick P Heinzel; Steven J Czinn; John G Nedrud
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

10.  Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense.

Authors:  John Y Kao; Sivaprakash Rathinavelu; Kathryn A Eaton; Longchuan Bai; Yana Zavros; Mimi Takami; Anna Pierzchala; Juanita L Merchant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-02-09       Impact factor: 4.052

View more
  10 in total

1.  Human primary gastric dendritic cells induce a Th1 response to H. pylori.

Authors:  D Bimczok; R H Clements; K B Waites; L Novak; D E Eckhoff; P J Mannon; P D Smith; L E Smythies
Journal:  Mucosal Immunol       Date:  2010-03-17       Impact factor: 7.313

2.  IRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cells.

Authors:  Tyler S Cole; Min Zhang; Theodore J Standiford; Michael Newstead; Jay Luther; Jiajie Zhang; Chun-Chia Chen; John Y Kao
Journal:  Immunol Lett       Date:  2012-03-28       Impact factor: 3.685

Review 3.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

4.  Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice.

Authors:  John Y Kao; Min Zhang; Mark J Miller; Jason C Mills; Baomei Wang; Maochang Liu; Kathyn A Eaton; Weiping Zou; Bradford E Berndt; Tyler S Cole; Tomomi Takeuchi; Stephanie Y Owyang; Jay Luther
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

Review 5.  Role of childhood infection in the sequelae of H. pylori disease.

Authors:  Paul R Harris; Lesley E Smythies; Phillip D Smith; Guillermo I Perez-Perez
Journal:  Gut Microbes       Date:  2013-11-06

6.  Impaired dendritic cell maturation and IL-10 production following H. pylori stimulation in gastric cancer patients.

Authors:  Lin-Li Chang; Sheng-Wen Wang; I-Chen Wu; Fang-Jung Yu; Yu-Chung Su; Ye-Pin Chen; Deng-Chyang Wu; Chang-Hung Kuo; Chih-Hsing Hung
Journal:  Appl Microbiol Biotechnol       Date:  2012-04-13       Impact factor: 4.813

7.  TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice.

Authors:  Xia Sun; Min Zhang; Mohamad El-Zataari; Stephanie Y Owyang; Kathryn A Eaton; Maochang Liu; Yu-Ming Chang; Weiping Zou; John Y Kao
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

8.  Lactic acid bacteria strains exert immunostimulatory effect on H. pylori-induced dendritic cells.

Authors:  Małgorzata Wiese; Andrzej Eljaszewicz; Anna Helmin-Basa; Marek Andryszczyk; Ilona Motyl; Jolanta Wieczyńska; Lidia Gackowska; Izabela Kubiszewska; Milena Januszewska; Jacek Michałkiewicz
Journal:  J Immunol Res       Date:  2015-02-22       Impact factor: 4.818

9.  CCR2 mediates Helicobacter pylori-induced immune tolerance and contributes to mucosal homeostasis.

Authors:  Xia Sun; Min Zhang; Mohamad El-Zaatari; Gray B Huffnagle; John Y Kao
Journal:  Helicobacter       Date:  2016-12-08       Impact factor: 5.753

10.  Leptin, CD4(+) T(reg) and the prospects for vaccination against H. pylori infection.

Authors:  Anna K Walduck; Dorit Becher
Journal:  Front Immunol       Date:  2012-10-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.